USPTO serial 79345489
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, science and medical research; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus; diagnostic biomarkers, namely, nucleic acids, proteins and other biochemical ligands for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for scientific research, clinical and medical laboratory use | ACTIVE | — |
| 005 | Diagnostic medical reagents and assay components for testing of body fluids including blood and plasma, and cells; diagnostic kits comprised of diagnostic reagents and assay components for clinical, medical and medical laboratory use; all the foregoing not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnostics | ACTIVE | — |
| 009 | Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology; laboratory apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyser providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analysing blood and blood cells not for medical use, and all for laboratory use, diagnostic or general research use; parts and fittings for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancer | ACTIVE | — |
| 010 | Medical apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases; medical testing apparatus, equipment and instruments for testing body fluids, blood and plasma, cancer cells, and foetal cells; medical testing kits for use in detecting cancerous conditions; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancer | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 23, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 4, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 3, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 5, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 6, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 13, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 1, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 1, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 1, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 26, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 26, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 26, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 26, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 26, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 26, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 10, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 19, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 19, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 6, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 26, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |